Starting today through Tuesday, the ATS 2023 International Conference Exhibit Hall will be open from 10:30 a.m.–3:30 p.m. ET. There will be a showroom floor with unique offerings, over 200 exhibitor booths to explore, program theaters offering CME sessions, and areas for attendees to relax and network.

The new ATS Networking Super Center is open to all International Conference attendees and will provide a centralized location to collaborate, connect, learn about ATS programs and member resources, and participate in specialized programming over the course of the conference.

The ATS International Conference Pediatric Year in Review session will feature four presentations that will explore pediatric exposome and the long-term impact on children’s health, as well as share insights into physician depression and burnout. This year’s topics address urgent needs for the well-being of pediatric providers and patients, according to Session Chair Benjamin T.…

During Sunday’s morning scientific symposium, a group of experts will discuss the challenges clinicians face when treating historically marginalized patients. Presenters will offer insights into various patient groups and share best practices for treating and advocating for them.

ATS 2023 attendees will get a chance to experience firsthand the consequences climate change has on the Earth through satellite data and visuals. This unique vantage point offers a peek into the effects of climate change on respiratory health.

Two Sunday sessions will highlight cutting-edge research published in the New England Journal of Medicine and the Journal of the American Medical Association. The forums will review the published research, including its direct application to critical care and pulmonary medicine, and the selection process for publication.

Eliseo J. Pérez-Stable, MD, Sunday morning’s Keynote speaker, will present “How Science Promotes Health Equity by Decreasing Disparities.” He will discuss health care disparities in minority communities and share data on the diversity of clinicians, researchers, and participants in clinical trials.

The leaders of four phase two and phase three trials will present the results of their research for the first time in a public forum on Monday at the International Conference. The Clinical Trials Symposium will highlight groundbreaking work on therapies for pulmonary hypertension, COPD, and asthma.

Shannon H. Kasperbauer, MD, and Doreen J. Addrizzo-Harris, MD, will chair the first of two joint sessions on bronchiectasis in collaboration with the American College of Chest Physicians (CHEST). Presentations will include research on identifying and diagnosing bronchiectasis, as well as therapeutics and treatments.

The ATS International Conference will recognize the 2023 Research Program Awardees at the Society’s annual Research Program Benefit on Saturday evening. Since 2004, the Research Program has awarded $22.8 million in research grants to 334 investigators.